The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin
Open accessAbstract
The aim of our study was to conduct a systematic review of studies evaluating antiviral therapy with pegylated interferon (PEG-IFN) alfa in combination with ribavirin for the management of recurrent hepatitis C after liver transplantation. Data sources included electronic databases and a manual search. Studies evaluating the efficacy and tolerability of PEG-IFN alfa with ribavirin in patients with recurrent hepatitis C were selected for inclusion. The information extracted from each of the selected publications included study design details, patient characteristics, treatment regimens and efficacy and tolerability end points. Nineteen studies including 611 patients were identified. PEG-IFN alfa-2b was used in 16 studies. The mean rate of SVR was 30.2% (range, 8-50%). Dose reduction and discontinuation of treatment were common in these studies (73% and 27.6%, respectively). The lack of an early virologic response (EVR) at 3 months of therapy was the most frequently described predictive factor of nonresponse. Treatment discontinuation and dose reductions due to adverse events were frequent and possibly represent important obstacles to attainment of SVR. EVR at 3 months of treatment should be considered an important predictor of treatment outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy†
Everson, G. T., Trotter, J., Forman, L., Kugelmas, M., Halprin, A., Fey, B., & Ray, C. (2005) · Hepatology · doi:10.1002/hep.20793 · Cited by 357
Carrión, J. A., Navasa, M., García-Retortillo, M., García‐Pagán, J. C., Crespo, G., Bruguera, M., Bosch, J., & Forns, X. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.041 · Cited by 347
Picciotto, F. P., Tritto, G., Lanza, A. G., Addario, L., De Luca, M., Di Costanzo, G., Lampasi, F., Tartaglione, M. T., Marsilia, G. M., Calise, F., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.017 · Cited by 195
Report of the Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis
Samuel, D., Forns, X., Berenguer, M., Trautwein, C., Burroughs, A., Rizzetto, M., & Trepo, C. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.001 · Cited by 161
Self-citationOton, E., Bárcena, R., Planas, J. M. M., Cuervas‐Mons, V., Moreno‐Zamora, A., Barrios, C., García-Garzón, S., Moreno, A. M., Boullosa-Graña, E., Rubio-González, E., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01470.x · Cited by 128
Preemptive Therapy for Hepatitis C Virus after Living-Donor Liver Transplantation
Sugawara, Y., Makuuchi, M., Matsui, Y., Kishi, Y., Akamatsu, N., Kaneko, J., & Kokudo, N. (2004) · Transplantation · doi:10.1097/01.tp.0000142677.12473.e5 · Cited by 112
Ross, A. S., Bhan, A. K., Pascual, M. A., Thiim, M., Cosimi, A. B., & Chung, R. T. (2004) · Clinical Transplantation · doi:10.1046/j.1399-0012.2003.00145.x · Cited by 99
Sharma, P., Marrero, J. A., Fontana, R. J., Greenson, J. K., Conjeevaram, H. S., Su, G. L., Askari, F. K., Sullivan, P., & Lok, A. S.-F. (2007) · Liver Transplantation · doi:10.1002/lt.21121 · Cited by 94
Cited by
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
(2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.003 · Cited by 855
Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C
Poordad, F., Lawitz, E., Kowdley, K. V., Cohen, D. E., Podsadecki, T., Siggelkow, S., Heckaman, M., Larsen, L., Menon, R., Koev, G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208809 · Cited by 285
Zanone, M. M., Marinucci, C., Ciancio, A., Cocito, D., Zardo, F., Spagone, E., Ferrero, B., Cerruti, C., Charrier, L., Cavallo, F., et al. (2021) · Liver International · doi:10.1111/liv.15002 · Cited by 19
Metadata
- Authors
- Berenguer, M.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 49
- Issue
- 2
- Pages
- 274-287
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W1985395902
- Cited by
- 342
- References
- 11
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin. https://app.cochat.ai/papers/10.1016/j.jhep.2008.05.002
- The paper
- Berenguer, M. (2008). Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2008.05.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
